Dr. Quan Zhang is an accomplished pharmaceutical scientist recognized for his contributions to targeted drug delivery and drugability optimization. His research focuses on developing advanced delivery platforms for tumor immunotherapy, brain disorders, and arthritis, along with improving the pharmacokinetic and therapeutic profiles of polyphenolic compounds and traditional Chinese medicine formulations. He has led numerous competitive research projects, including national-level grants and industry collaborations, and has played a key role in advancing both basic and applied pharmaceutical studies. His work has resulted in a substantial body of high-impact publications, several invention patents, and contributions to academic textbooks. Dr. Zhang has made notable advances in biomimetic nanomedicine, tumor microenvironment–responsive therapeutics, and innovative formulations for alcohol intoxication management, including the discovery of novel active compounds and the development of commercial health products. His research outcomes have influenced the fields of cancer therapy, neurodegenerative disease treatment, and anti-inflammatory drug strategies, integrating molecular design with translational pharmaceutical technology. He has been recognized through talent programs and scientific awards, reflecting his leadership in pharmaceutics and his impact on interdisciplinary drug research.

Profile: Scopus

Featured Publications

Zhang, Q., et al. (2024). Current advances in biomimetic drug delivery system for targeted therapy of rheumatoid arthritis. Acta Pharmaceutica Sinica B.

Zhang, Q., et al. (2024). Co-delivery nanoparticle targeting CAF for simultaneous activating T cell plus NK cell attack in solid tumor. Journal of Controlled Release.

Deng, C., Zhang, Q., Jia, M., Zhao, J., Sun, X., Gong, T., & Zhang, Z. (2019). Tumors and their microenvironment dual-targeting chemotherapy with local immune adjuvant therapy for effective antitumor immunity against breast cancer. Advanced Science, 6, 1801868.

Deng, C., Zhang, Q., He, P., Zhou, B., He, K., Sun, X., Lei, G., Gong, T., & Zhang, Z. (2021). Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis. Nature Communications, 12, 2174.

Mao, J., Liu, X., Zhang, L., Chen, Y., Zhou, S., Liu, Y., Ye, J., Xu, X., & Zhang, Q. (2024). Self-nanoemulsifying drug delivery system of morin: A new approach for combating acute alcohol intoxication. International Journal of Nanomedicine, 19, 10569–10588.